Literature DB >> 17893694

Evolving functions of endothelial cells in inflammation.

Jordan S Pober1, William C Sessa.   

Abstract

Inflammation is usually analysed from the perspective of tissue-infiltrating leukocytes. Microvascular endothelial cells at a site of inflammation are both active participants in and regulators of inflammatory processes. The properties of endothelial cells change during the transition from acute to chronic inflammation and during the transition from innate to adaptive immunity. Mediators that act on endothelial cells also act on leukocytes and vice versa. Consequently, many anti-inflammatory therapies influence the behaviour of endothelial cells and vascular therapeutics influence inflammation. This Review describes the functions performed by endothelial cells at each stage of the inflammatory process, emphasizing the principal mediators and signalling pathways involved and the therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893694     DOI: 10.1038/nri2171

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  635 in total

1.  Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.

Authors:  Lisa A Madge; Michael J May
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 2.  Endothelial nanomedicine for the treatment of pulmonary disease.

Authors:  Jacob S Brenner; Colin Greineder; Vladimir Shuvaev; Vladimir Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2014-11-14       Impact factor: 6.648

3.  Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots.

Authors:  Ziv Shulman; Shmuel J Cohen; Ben Roediger; Vyacheslav Kalchenko; Rohit Jain; Valentin Grabovsky; Eugenia Klein; Vera Shinder; Liat Stoler-Barak; Sara W Feigelson; Tsipi Meshel; Susanna M Nurmi; Itamar Goldstein; Olivier Hartley; Carl G Gahmberg; Amos Etzioni; Wolfgang Weninger; Adit Ben-Baruch; Ronen Alon
Journal:  Nat Immunol       Date:  2011-12-04       Impact factor: 25.606

4.  Ischemia induces P-selectin-mediated selective progenitor cell engraftment in the isolated-perfused heart.

Authors:  Jeremy Alan Elser; Brendan P Purcell; Irshad A Allana; Jason A Burdick; Kenneth B Margulies
Journal:  J Mol Cell Cardiol       Date:  2011-10-25       Impact factor: 5.000

5.  Loss of Estrogen-Related Receptor Alpha Facilitates Angiogenesis in Endothelial Cells.

Authors:  Neah Likhite; Vikas Yadav; Eric J Milliman; Danesh H Sopariwala; Sabina Lorca; Nithya P Narayana; Megha Sheth; Erin L Reineke; Vincent Giguère; Vihang Narkar
Journal:  Mol Cell Biol       Date:  2019-02-15       Impact factor: 4.272

6.  ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration.

Authors:  Roberta Martinelli; Matthew Gegg; Rebecca Longbottom; Peter Adamson; Patric Turowski; John Greenwood
Journal:  Mol Biol Cell       Date:  2008-12-10       Impact factor: 4.138

Review 7.  Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity.

Authors:  Dimitris N Xanthos; Jürgen Sandkühler
Journal:  Nat Rev Neurosci       Date:  2013-11-27       Impact factor: 34.870

8.  Engineering "Endothelialized" Microfluidics for Investigating Vascular and Hematologic Processes Using Non-Traditional Fabrication Techniques.

Authors:  Robert G Mannino; Navaneeth Kr Pandian; Abhishek Jain; Wilbur A Lam
Journal:  Curr Opin Biomed Eng       Date:  2017-12-05

Review 9.  Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis.

Authors:  Binod Aryal; Yajaira Suárez
Journal:  Vascul Pharmacol       Date:  2018-03-15       Impact factor: 5.773

Review 10.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.